CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in ST Elevation Myocardial Infarction
Overview
- Phase
- Not Applicable
- Intervention
- MRI
- Conditions
- Myocardial Infarction
- Sponsor
- Hospices Civils de Lyon
- Enrollment
- 300
- Locations
- 2
- Primary Endpoint
- Research of potential new markers
- Status
- Recruiting
- Last Updated
- 3 months ago
Overview
Brief Summary
ST-segment elevation myocardial infarction (STEMI) is an acute condition that accounts for 75% of sudden deaths in adults over 35 years of age and more than half of all cases of chronic heart failure. However, the mechanism of myocardial infarction remains poorly understood. At present, there is no national information system for myocardial infarction, as there is for other diseases such as multiple sclerosis (OFSEP cohort).
The purpose of this cohort is to enable studies and research projects to be carried out on the descriptive epidemiology of myocardial infarction, monitoring of patients undergoing treatment (safety, efficacy), quality of life and functional consequences of infarction, and research into new biological and imaging prognostic biomarkers. Its general objective is to provide researchers, hospital practitioners, medical interns, academics or industrialists with a quality epidemiological tool for research.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age ≥ 18 years
- •Diagnosis of STEMI defined by ST segment elevation ≥ 0.2 mV in 2 contiguous leads on a 12-lead ECG.
- •Management in primary ACT
- •Prior oral informed consent followed by signed informed consent as soon as possible.
Exclusion Criteria
- •Diagnosis of STEMI not confirmed on angiography
- •Inability to give the subject informed information
- •Lack of coverage by a social security scheme
- •Obvious contraindication to injected magnetic resonance imaging (claustrophobia, pacemaker, defibrillator, or a metallic body (ferromagnetic), severe renal insufficiency (GFR\<30 ml/min), known allergy to the contrast medium ....)
- •Pregnant woman or woman of childbearing age without effective contraception, breastfeeding woman.
- •Deprivation of civil rights (curators, guardianship, safeguard of justice)
Arms & Interventions
Cohort group
patient with ST-segment elevation myocardial infarction.
Intervention: MRI
Cohort group
patient with ST-segment elevation myocardial infarction.
Intervention: Biocollection
Cohort group
patient with ST-segment elevation myocardial infarction.
Intervention: Quality of life questionaries
Outcomes
Primary Outcomes
Research of potential new markers
Time Frame: 1 year
Biomarkers assays (prognosis and diagnosis) between inclusion and one-year follow-up (H0, H4, H24, H48, M1, M12 since emergency revascularisation)
Secondary Outcomes
- Pharmacoepidemiology of myocardial infarction.(5 years)
- Calculation of infarct size on MRI(1 month)
- Events between inclusion and 5 years follow-up(5 years)